Revision as of 03:39, 29 October 2013

Achievements

Won the trophy for Best Model at the iGEM North America Jamboree in Toronto
Advanced to the iGEM final Jamboree at MIT with gold medal status
Produced a functional cinnamaldehyde biosynthetic pathway in E. coli starting from phenyalanine
Produced a functional vanillin biosynthetic pathway in E. coli starting from p-coumaric acid
Biobricked Cas9, showed expression and began to characterize it's activity E. coli

Submitted Cas9 (BBa_K1129006) as our favorite functional part and showed evidence of immunity against phage using CRISPR components.
Obtained ethics approval to survey public’s perception of GMOs with the aim to create a marketing strategy for a GM Yogurt, following interviews with dairy industry and academic professionals

@@ Line 81: / Line 81: @@
 <li>Submitted 40 and characterized 25 new <a href="https://2013.igem.org/Team:British_Columbia/Parts">biobrick parts</a></li>
 </ul>
+<ul class="s">
+<li>Submitted Cas9 (<a href="http://parts.igem.org/wiki/index.php?title=Part:BBa_K1129006">BBa_K1129006</a>) as our favorite functional part and showed evidence of immunity against phage using CRISPR components. </li>
+<li>Obtained <a href="https://2013.igem.org/Team:British_Columbia/humanpractices/EthicsApproval">ethics approval</a> to <a href="https://2013.igem.org/Team:British_Columbia/humanpractices/ConductSurvey"> survey public’s perception</a> of GMOs with the aim to create a <a href="https://2013.igem.org/Team:British_Columbia/marketing">marketing strategy for a GM Yogurt</a>, following <a href="https://2013.igem.org/Team:British_Columbia/humanpractices/Interviews">interviews</a> with dairy industry and academic professionals </li>
+</ul>
 </div>
 </html>